INSIDE almost every modern car, surgical device, and firearm mechanism sits a small, complex metal part few people ever think about — and there is a strong chance it was engineered in Bengaluru. Indo-MIM Limited, founded in 1996, has grown into the world's largest manufacturer using Metal Injection Molding (MIM) technology, a precision process for producing intricate metal components at scale. With a mainboard initial public offering worth approximately ₹3,811 crore now before Indian investors, the company's decades-long journey as a quiet, export-driven engineering powerhouse is coming into public view.

————  ◆  ————

❖  A PRECISION ENGINEERING STORY SINCE 1996

Indo-MIM Limited was established in 1996 and has since built its reputation around one core capability: producing small, geometrically complex, high-tolerance metal components at industrial scale. The company is headquartered at KIADB Industrial Area, Hoskote, near Bengaluru, Karnataka, and has grown from a specialised toolmaker into a global, multi-technology precision manufacturing group.

Over three decades, Indo-MIM expanded well beyond its original MIM capability to offer a complete manufacturing solution, including product design support, tooling, precision machining, investment casting, ceramic injection molding, additive manufacturing (3D metal printing), finishing, surface treatment and final assembly — effectively taking a component from design concept to finished, assembled part under one roof.

❖  TECHNOLOGY AND PRODUCT RANGE

Metal Injection Molding combines the design flexibility of plastic injection molding with the strength and density of machined metal, allowing manufacturers to produce complex parts in large volumes with minimal secondary machining. Indo-MIM has built the world's largest installed MIM manufacturing capacity, and layers this with investment casting, ceramic injection molding and 3D metal printing to cover an unusually broad span of precision-manufacturing needs. In FY2025, the company manufactured more than 6,400 distinct products, supplied into automotive, aerospace, defence, medical devices, consumer products and industrial engineering applications.

❖  GLOBAL MANUFACTURING FOOTPRINT

As of March 31, 2026, Indo-MIM operated 15 manufacturing facilities spread across India, the United States, the United Kingdom and Mexico. Its commercial reach is equally global: the company maintains sales offices in China, Germany and the United States, backed by a network of sales representatives spanning the Czech Republic, France, Italy, Japan, South Korea, Israel, Poland and other markets across Europe and Asia. During FY2026, Indo-MIM served more than 1,100 customers worldwide, though its top 10 customers still accounted for roughly 38.41% of total revenue, underlining some concentration risk alongside its broad reach.

❖  FINANCIAL PERFORMANCE

Indo-MIM's financial trajectory reflects sustained growth alongside improving balance-sheet discipline. Consolidated revenue rose from ₹3,329.58 crore in FY25 to ₹4,192.99 crore in FY26, an increase of nearly 26%. Profit after tax grew in step, climbing from ₹423.73 crore to ₹533.54 crore over the same period, also a rise of roughly 26%. The company reported an EBITDA margin of 25.54% and a PAT margin of 12.72% in FY26, alongside a Return on Capital Employed (ROCE) of 26.60% and Return on Net Worth of 21.26%. Total borrowings declined from approximately ₹1,247 crore in FY25 to ₹1,090 crore in FY26, helping improve the debt-to-equity ratio from 0.57 to 0.39.

❖  THE 2026 INITIAL PUBLIC OFFERING

Indo-MIM's mainboard IPO is a book-built issue worth approximately ₹3,811 crore, comprising a fresh issue of around ₹499–500 crore and an Offer for Sale of roughly ₹3,311–3,312 crore by existing shareholders. The price band has been fixed at ₹461 to ₹485 per share, with a minimum lot size of 30 shares, translating to a minimum retail investment of about ₹14,550 at the upper band. The issue opened for subscription on July 23, 2026 and closed on July 27, 2026, with allotment expected on July 28 and listing tentatively scheduled for July 30, 2026 on both the NSE and BSE.

Of the fresh issue proceeds, approximately ₹400 crore is earmarked for repaying outstanding borrowings, with the remainder set aside for general corporate purposes. Ahead of the offer, the promoter group — comprising Green Meadows Investments Ltd, Krishna Chivukula, Krishna Chivukula Jr, Raj Chivukula and Jagadamba Chandrasekhar — held approximately 92.94% of the company, a stake expected to decline to around 77.65% following the Offer for Sale. Indo-MIM raised roughly ₹1,141 crore from anchor investors ahead of the public offer.

❖  WHY THE BUSINESS MATTERS

❖ Category leadership: Indo-MIM holds the world's largest installed MIM manufacturing capacity and a 6.8% global market share in a highly specialised process technology.

❖ Diversified end markets: exposure spans automotive, aerospace, defence, medical devices, consumer products and industrial engineering, reducing reliance on any single sector.

❖ Global manufacturing base: 15 facilities across India, the US, the UK and Mexico support proximity to major customers and supply chains.

❖ Improving balance sheet: a falling debt-to-equity ratio, healthy ROCE and planned debt repayment from IPO proceeds point to strengthening financial discipline.

❖  OUTLOOK

As industries from electric vehicles to medical devices demand smaller, lighter and more complex metal components, Indo-MIM's multi-technology precision-manufacturing platform positions it at the center of that shift. The company is also investing in backward integration, including a planned facility in Karnataka to produce its own iron powder by the end of FY27, aimed at strengthening raw-material supply reliability. Whether viewed as a specialised industrial technology story or as a newly listed public company, Indo-MIM's evolution from a 1996 toolmaking venture into a global precision-engineering leader offers a compelling case study in focused, technology-led growth.

————  ◆  ————

  Disclaimer: This article is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Figures relating to the IPO, market share and financials are drawn from publicly available company and market disclosures and may change. Grey market premium (GMP) figures are unofficial and can fluctuate significantly before listing. Readers should consult official offer documents and a licensed financial advisor before making investment decisions.